Active Immunisation ACI-7104.056, an adjuvanted protein peptide conjugate vaccine, is currently under investigation at different doses in a phase 2 placebo-controlled trial (NCT06015841), with positive interim results reported by the company in November 2024 [101] but no peer-reviewed publication yet
Except for hDPCs, the proliferation of human ORS cells, human germinal matrix cells, and hHFSCs was also stimulated by octapeptide treatment
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
Additionally, independent testing by third-party labs can verify the purity and stability of the peptide
What to do right now Note the time and dose you took
Still, research shows that GLP-1 drugs can produce the most significant weight loss